A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris (Q83355771)
Jump to navigation
Jump to search
scientific article published on 01 June 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris |
scientific article published on 01 June 2006 |
Statements
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris (English)
Kragballe K
Austad J
Barnes L
Bibby A
de la Brassinne M
Cambazard F
Fleming C
Heikkilä H
Jolliffe D
Peyri J
Svensson A
Toole J